Andreas H. Wagner

Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation

Andreas H. Wagner, Thomas Köhler, Uwe Rückschloss et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 518 citations

Life Sciences, Biochemistry, Pharmacology +17

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2018 · 455 citations

Medicine, Cardiology, Pharmacology +16

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2020 · 265 citations

Medicine, Cardiology, Internal Medicine +16

17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells

Andreas H. Wagner, Marco R. Schroeter, Markus Hecker · The FASEB Journal · 2001 · 223 citations

Life Sciences, Endocrinology, Pharmacology +17

von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans

Alexander T. Bauer, Jan Suckau, K Frank et al. · Blood · 2015 · 159 citations · Full text

Medicine, Cell Biology, Oncology +16